miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F

Xiangyang YeDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Rongxian QiuDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Xiongzhi HeDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Zhengting HuDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Fengfeng ZhengDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Xiaogang HuangDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Xuemei XieDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Feihua ChenDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Hangbing OuDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information

Guoxian LinDepartment of Infectious Diseases, Affiliated Hospital of Putian University, Putian, Fujian, ChinaCorrespondence[email protected]
View further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.